People’s Choice LabVIEW Idea Implementation

[vitoi]

This idea came about from a discussion at http://forums.ni.com/t5/LabVIEW-Idea-Exchange/Require-LabVIEW-R-amp-D-response-to-any-idea-over-N-ku...

The idea is to give LabVIEW users some say in which ideas are implemented. The key components of the idea are:

1) Set aside 5% of NI’s R&D staff to work on the “people’s choice” LabVIEW idea. That’s over 100 R&D staff, so a lot can be done.

2) Take LabVIEW ideas with kudos of 200 or more (there are 39 unimplemented ideas with 200 or more kudos).

3) Put together a poll of these 39 ideas and ask LabVIEW users to vote for their favourite.

4) Keep the poll open for 2 weeks and at the end of the period, take the idea with the most votes and implement it.

5) Once the idea is in beta, another "people's choice" poll is conducted and the process repeated. (Small ideas get implemented quickly, bigger ideas presumably are worth the wait.)

The 5% R&D staff, 200 kudos, etc figures can be played with to get the desired result.

I think we'll get more smiles on our faces from the 5% of R&D staff working on the "people's choice" project than we'll get from the 95% working on the "marketing's choice" projects.

[vitoi]

Financial figures for 2012 now available:

* National Instruments: Down 2.5%

* Agilent: Up 14.2%

* Nasdaq: Up 13.6%

* Russell 2000: Up 13.1%

The relevant indices and Agilent are all up about 13 to 14% (and remarkably close to each other). National Instruments down 2.5% over the year (or down 14.2% relative to the Nasdaq).

Not a good year. Let's hope 2013 is kinder. Looking for a game changing innovation from National Instruments.

[vitoi]

The share price figures for the two years 2012 and 2013 are now available:

* National Instruments: Up 20.9%

* Agilent: Up 59.6%

* Nasdaq: Up 57.2%

* Russell 2000: Up 55.0%

The relevant indices and Agilent are all up about 55 to 60% (and remarkably close to each other). National Instruments up only 20.9% over the two years (or down 23.3% relative to the Nasdaq).

Over the past two years, on average, the National Instruments share price has dropped about 1% per month relative to the Nasdaq.

National Instruments has the innovative technology to outperform the market. However, marketing is flogging the hardware and retarding revenue growth and customer satisfaction. LabVIEW could be much more prevalent than it is now if the LabVIEW Everywhere concept is reignited and truly pursued.